Regulation of cellular therapies: The Australian perspective

Cytotherapy

Volumn 5, Issue 4, 2003, Pages 284-288

  Wall, D M P ^a   Prince, H Miles ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; APHERESIS; AUSTRALIA; AUTOTRANSPLANTATION; BLOOD CELL; BLOOD COMPONENT; GOOD MANUFACTURING PRACTICE; GOVERNMENT; HEMATOPOIETIC STEM CELL; LABORATORY; LICENSING; MEDICAL AUDIT; PLASMA; PRACTICE GUIDELINE; QUALITY CONTROL; SHORT SURVEY; STANDARD; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

EID: 0142094692     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310002207     Document Type: Review

References (8)

1. Council of Europe Guidelines for Human Blood and Blood Components. 8th edn. Council of Europe (CoE), 2002.
2. Guide to Safety and Quality Assurance for Organs, Tissues and Cells. 1st edn. CoE, 2002.
3. Standards for Hematopoietic Progenitor Cell Collection, Processing and Transplantation. 2nd edn. FACT, 2002.
4. International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release. 2nd edn. NETCORD and FAHCT, 2001.
5. Standards for Hematopoietic Progenitor Cell and Cellular Product Services. 3rd edn. American Association of Blood Banks (AABB), 2002.
6. Standards for Cord Blood Services. 1st edn. AABB, 2001.
7. Guidelines for the Blood Transfusion Services in the United Kingdom. 5th edn. London: The Stationery Office, 2001.
8. Guidelines for Laboratory Procedures Related to the Processing, Storage and Infusion of Haemopoietic Stem Cells for Transplantation from Bone Marrow, Mobilised Peripheral Blood and Umbilical Cord Blood. 1st edn. National Pathology Accreditation Advisory Council (NPAAC), 1999.